Nexalin Technology NXL
NASDAQ NXL
$2.10 +0.07 (+3.20%)
As of: Oct 22, 2026 · 11:42 AM EDT

Nexalin Technology (NXL) EBITDA (2021 - 2026)

Updated

Nexalin Technology (NXL) recorded EBITDA of -$2.22 million in Q2 2026.

Analysis

Nexalin Technology (NXL) EBITDA (2021 - 2026) Analysis & Trends

On a TTM basis, Nexalin Technology's EBITDA came in at -$8.37 million as of Jun 30, 2026; for FY2023, it was -$5.69 million.

  • Across earlier years, EBITDA came in at -$1.83 million in FY2022 and -$6.02 million in FY2021.
  • The Q2 2026 figure is the lowest quarterly EBITDA since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Thermo Fisher Scientific 253.19 Bn 232.22 Bn 4.88 Bn 2.90 Bn
2 Abbott Laboratories 177.78 Bn 148.21 Bn 7.27 Bn 2.75 Bn
3 Danaher 164.28 Bn 148.09 Bn 3.61 Bn 1.79 Bn
4 Intuitive Surgical 155.73 Bn 135.16 Bn 1.96 Bn 1.19 Bn
5 Medtronic 122.75 Bn 88.00 Bn 6.34 Bn 2.49 Bn
6 Stryker 118.23 Bn 104.35 Bn 4.50 Bn 1.96 Bn
7 Boston Scientific 67.03 Bn 61.80 Bn 3.85 Bn 1.53 Bn
8 Becton Dickinson 54.59 Bn 51.74 Bn 2.32 Bn 1.23 Bn
9 Edwards Lifesciences 51.62 Bn 35.62 Bn 1.35 Bn 555.90 Mn
10 Nexalin Technology 1.48 Mn -10.31 Mn 8,897.00 -2.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.22 Mn
Mar 31, 2026 -2.11 Mn
Dec 31, 2023 -1.62 Mn
Sep 30, 2023 -2.41 Mn
Jun 30, 2023 -876,034.00
Mar 31, 2023 -778,632.00
Dec 31, 2022 -719,485.00
Sep 30, 2022 -293,059.00
Jun 30, 2022 -444,969.00
Mar 31, 2022 -374,983.00
Dec 31, 2021 -577,355.00
API Access

Nexalin Technology EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=NXL&period=max&api_key=YOUR_API_KEY